News items related to: Opinion
-
TEDWomen: Why are drug prices so high?
Hear from I-MAK’s Priti Krishtel on how the outdated patent system is the hidden reason that drug prices are so high...
-
The problem with patents: Commitments to HIV and universal health coverage are being undermined in middle-income countries
A joint blog by Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC),...
-
Brazilian Health Minister’s speech on compulsory licenses exposes a disconnect with the world
Adapted from a story first published by GTPI. Compulsory licensing is a vital public policy tool to combat the high...
-
Still an avoidable tragedy: Brazil’s view on the EU-Mercosur free-trade agreement
The signing of the Free Trade Agreement (FTA) between Mercosur and the European Union on 28 June 2019, means that...
-
Old wine in new bottles: Keep TRIPS-plus provisions out of the RCEP FTA!
Intellectual property barriers, which would hinder access to affordable medicines, have supposedly been removed from the draft RCEP free-trade agreement...
-
Politics of Death: The End of Brazil’s Department of AIDS
Adapted from a post published by ABIA, Global AIDS Policy Watch: A joint story from Brazilian NGOs that have denounced...
-
Watching Brazil: In defence of democracy and human rights
Author: Andresa Porto – Political Scientist and member of GTPI. Now that the Brazilian government’s new party blocs have been...
-
Watching Brazil. New monthly column analyzing the impact of Bolsonaro’s politics on civil society and access to medicines
Author: Andresa Porto – Political Scientist and member of GTPI.Translated from Portuguese, original version here. This is the first of...
-
The problem with high drug prices isn’t ‘foreign freeloading,’ it’s the patent system
Today’s drug patent monopolies are stronger than at any point in the last century, raising prescription prices, reports Tahir Amin...
-
39 developing countries excluded from optimal HIV treatment – a dangerous oversight or deliberate tactic?
This World AIDS Day (1 December 2017), we’re pleased to have reached a point where more people are set to...
-
“We want dolutegravir for all, and we want it now.”
Article first published on the Huffington Post here. We’re calling for a compulsory license on a ‘new’ HIV drug to...